Literature DB >> 17846867

Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.

Adam W G Alani1, Joseph R Robinson.   

Abstract

PURPOSE: Examine the oral absorption enhancement mechanism of cromolyn sodium by sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) by evaluating the effect of SNAC on cromolyn sodium lipophilicity and changes in Caco-2 cell membrane fluidity.
MATERIALS AND METHODS: Standard Shake-flask method was used to evaluate the effect of SNAC on the lipophilicity of cromolyn sodium. The measurements were carried out in three partitioning solvents with varying hydrogen-bonding properties. Steady state fluorescence emission anisotropy technique was used to evaluate the effect of SNAC with/without cromolyn sodium on Caco-2 cell membrane fluidity.
RESULTS: The lipophilicity measurements showed that SNAC had no influence on the lipophilicity of cromolyn sodium in the three partitioning solvent systems. The findings of the steady-state fluorescence anisotropy showed that SNAC increases the membrane fluidity of the Caco-2 cells in a concentration dependent manner. The increase in fluidity with SNAC was seen in the presence and absence of cromolyn sodium and the presence of cromolyn sodium did not augment the effect of SNAC on membrane fluidity.
CONCLUSIONS: The increase in membrane fluidity by SNAC plays a pivotal role in the permeation enhancement mechanism of cromolyn sodium. Therefore, the increase in permeation is a result of changing Caco-2 cell membrane fluidity resulting in change in membrane integrity and not due to an increase in the lipophilicity of cromolyn sodium through its interaction with SNAC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846867     DOI: 10.1007/s11095-007-9438-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro.

Authors:  A Leone-Bay; H Leipold; D Sarubbi; B Variano; T Rivera; R A Baughman
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin.

Authors:  A Leone-Bay; D R Paton; J Freeman; C Lercara; D O'Toole; D Gschneidner; E Wang; E Harris; C Rosado; T Rivera; A DeVincent; M Tai; F Mercogliano; R Agarwal; H Leipold; R A Baughman
Journal:  J Med Chem       Date:  1998-03-26       Impact factor: 7.446

3.  Effect of complex formation on drug absorption. XIV. Effect of N,N-di-n-propylpropionamide on intestinal absorption of certain nonsteroid drugs in the rat.

Authors:  W L Hayton; G Levy; C G Regårdh
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

4.  Effect of complex formation on drug absorption. XI. Complexation of prednisone and prednisolone with dialkylpropionamides and its effect on prednisone transfer through an artificial lipoid barrier.

Authors:  W L Hayton; D E Guttman; G Levy
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

5.  Effect of complex formation on drug absorption. 13. Effect of constant concentrations of N, N-di-n-propylpropionamide on prednisolone absorption from the rat small intestine.

Authors:  W L Hayton; G Levy
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

6.  Effect of complex formation on drug absorption. XV. Structural requirements for enhancement of intestinal absorption of steroids by N,N-di-n-propylpropionamide.

Authors:  W L Hayton; G Levy
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

7.  Microsphere formation in a series of derivatized alpha-amino acids: properties, molecular modeling, and oral delivery of salmon calcitonin.

Authors:  A Leone-Bay; C McInnes; N Wang; F DeMorin; D Achan; C Lercara; D Sarubbi; S Haas; J Press; E Barantsevich
Journal:  J Med Chem       Date:  1995-10-13       Impact factor: 7.446

8.  Oral absorption enhancement of cromolyn sodium through noncovalent complexation.

Authors:  Xuan Ding; Parshuram Rath; Robert Angelo; Thomas Stringfellow; Elizabeth Flanders; Steven Dinh; Isabel Gomez-Orellana; Joseph R Robinson
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

9.  Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.

Authors:  Bhagwant D Rege; Joseph P Y Kao; James E Polli
Journal:  Eur J Pharm Sci       Date:  2002-09       Impact factor: 4.384

10.  Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility.

Authors:  E S Swenson; W B Milisen; W Curatolo
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

View more
  6 in total

Review 1.  Absorption enhancers: applications and advances.

Authors:  Bruce J Aungst
Journal:  AAPS J       Date:  2011-11-22       Impact factor: 4.009

Review 2.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

Review 3.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

4.  Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Melanie Davies; Thomas R Pieber; Marie-Louise Hartoft-Nielsen; Oluf K H Hansen; Serge Jabbour; Julio Rosenstock
Journal:  JAMA       Date:  2017-10-17       Impact factor: 56.272

5.  Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability.

Authors:  Hao Chen; Yun Lu; Shuai Shi; Qiang Zhang; Xiaoli Cao; Lei Sun; Dong An; Xiaojie Zhang; Xianglin Kong; Jianping Liu
Journal:  Pharm Res       Date:  2022-06-13       Impact factor: 4.580

6.  Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.

Authors:  Adam W G Alani; Joseph R Robinson
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.